Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SMPDL3B gene

Known as: ASML3B, SMPDL3B, sphingomyelin phosphodiesterase acid like 3B 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Current outcome prediction markers for localized prostate cancer (PCa) are insufficient. The impact of the lipid-modifying… Expand
  • figure 2
  • figure 2
  • figure 3
  • figure 4
2017
2017
Rituximab (RTX), a specific antibody to human CD20, has been successfully used to treat intractable nephrotic syndrome (NS… Expand
2016
2016
The enzyme acid sphingomyelinase-like phosphodiesterase 3B (SMPDL3B) was shown to act as a negative regulator of innate immune… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
of a dissertation at the University of Miami. Dissertation supervised by Professor Sandra Merscher. No. of pages in text. (102… Expand
  • figure 1.1
  • figure 1.2
  • figure 3.1
  • figure 3.2
  • figure 3.3
Highly Cited
2015
Highly Cited
2015
Diabetic kidney disease (DKD) is the most common cause of ESRD in the United States. Podocyte injury is an important feature of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2015
Highly Cited
2015
Summary Lipid metabolism and receptor-mediated signaling are highly intertwined processes that cooperate to fulfill cellular… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2014
Review
2014
Sphingolipids are components of the lipid rafts in plasma membranes, which are important for proper function of podocytes, a key… Expand
  • figure 1
  • figure 2
  • table 1
2014
2014
Given the shortage of organs available for transplantation and the rising prevalence of ESRD,[1][1] new avenues including xeno… Expand